6 nominees · 5 ballot items.
Shareholders will vote to elect six directors; ratify Cherry Bekaert LLP as the Company’s independent auditors for fiscal 2026; approve an amendment to the 2018 Equity Incentive Plan to increase authorized shares and annual award limits; approve a non-binding advisory 'say-on-pay' on executive compensation; and approve an adjournment authorization to allow the Board to postpone the meeting to solicit additional proxies or provide supplemental disclosure.
Elect six nominees (Mitchell S. Steiner, Harry Fisch, Michael L. Rankowitz, Grace Hyun, Lucy Lu, and Loren Katzovitz) to the Board of Directors to serve until the 2027 Annual Meeting.
Ratify the Audit Committee’s appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026.
Approve an amendment to the 2018 Equity Incentive Plan to increase authorized shares from 2,600,000 to 5,850,000, increase the annual individual award limit for participants (other than non-employee directors) from 100,000 to 750,000 shares, and increase the annual award limit for non-employee directors from 10,000 to 120,000 shares.
This proposal asks shareholders to approve a material amendment to the Company’s 2018 Equity Incentive Plan that would add 3,250,000 shares to the plan reserve (increasing it from 2,600,000 to 5,850,000) and materially raise annual award limits for employees and non-employee directors. Management is seeking approval because the Company has a limited remaining share pool (only 647,603 shares available under existing plans as of January 14, 2026) and a significant portion of outstanding options have exercise prices well above the current market price, limiting the effectiveness of the current equity program as a retention and incentive tool. The Board frames the amendment as necessary to attract, motivate and retain key personnel without resorting to cash compensation, which it views as less alignment-focused and more cash-consuming. The filing provides shareholder-focused safeguards such as a 12‑month minimum vesting rule (with limited exceptions), prohibition on re-pricing without shareholder approval, a fungible ratio that counts full-value awards as two shares, a ten-year plan term, and administration by an independent Compensation Committee. Material trade-offs include increased dilution: the Company estimates the additional shares would represent roughly 20.2% of outstanding shares as of January 14, 2026 and would raise the fully-diluted overhang from 7.4% to 13.9% if approved. The proposal therefore balances the operational need to grant meaningful, market-competitive equity awards against shareholder dilution; management argues the benefits (improved retention and alignment) outweigh the dilution, while shareholders should weigh the scale of the increase and the governance protections provided. The Board’s recommendation is FOR, citing the competitive labor market, the underwater nature of existing options, and the plan features designed to limit abuse. The vote required is a simple majority of votes cast; abstentions will be treated as votes AGAINST. Given the plan features and the Company’s factual context (small employee base, large outstanding high-exercise-price option pool), the proposal is pragmatically defensible but will be scrutinized by investors sensitive to dilution and historical burn rates.
A non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the Proxy Statement.
This advisory proposal asks shareholders to approve, on a non-binding basis, the Company’s executive compensation as disclosed in the proxy, effectively a 'say-on-pay' ratification of the Compensation Committee’s program. Management argues the program is clear and simple—consisting primarily of base salary, annual performance awards tied to corporate and individual goals, and equity incentive awards—and is deliberately designed to promote pay-for-performance and long-term alignment through equity. The Compensation Committee is independent and has adopted practices such as an annual incentive program with corporate and stretch goals, equity grants with vesting schedules, and no supplemental pension or perquisites for named executives; the Company also has a clawback policy to recoup certain incentive awards in the event of a restatement. Countervailing governance context includes the Company’s recent financial performance (net losses in recent years and declining TSR) and that a substantial portion of equity awards are underwater, which can complicate retention and perceived alignment. The vote is non-binding but the Board says it will consider the outcome when setting future compensation. For investors, the question is whether the incentives and disclosures sufficiently tie pay to measurable performance while controlling excessive compensation given the Company’s financial outcomes; the Board recommends FOR, citing alignment, committee oversight, and the pay mix. A negative advisory vote would likely trigger a shareholder engagement and potential changes to the compensation program.
Authorize the Board to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies or allow time for supplemental or amended disclosure if there are not sufficient votes to approve other proposals.
This proposal requests shareholder approval to empower the Board (and holders of proxies solicited by the Board) to adjourn the Annual Meeting to a later date or time if, in the Board’s view, doing so is necessary or appropriate—principally to solicit additional proxies or to permit distribution of supplemental or amended disclosure. Management seeks this authority as a practical measure to avoid failed votes on material proposals and to provide time to engage with shareholders. The proposal is routine in many proxy contests and transactions but raises governance trade-offs: while adjournment can enable constructive engagement and additional proxy solicitation to secure approval for proposals the Board believes necessary, it can also be used to delay or alter the timing of a shareholder decision and provide additional opportunities to influence outcomes. The Company notes shareholders who have already submitted proxies may revoke them prior to use, preserving shareholder control; approval requires a majority of votes cast. The Board recommends FOR, arguing that adjournment is in shareholders’ best interests to pursue approvals for matters critical to company operations. Investors should weigh the operational utility of the authority against the risk that it could be used to overcome active shareholder opposition without additional substantive changes to proposals.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Alyeska Investment Group, L.P. | 6.2% | 1,000,000 | $2M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 539,382 | $1M |
| 3 | OPPENHEIMER CO INC | 1.2% | 196,300 | $434K |
| 4 | GSA CAPITAL PARTNERS LLP | 1.2% | 189,699 | $419K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.0% | 152,855 | $338K |
| 6 | Summit Financial, LLC | 0.9% | 151,783 | $335K |
| 7 | MILLENNIUM MANAGEMENT LLC | 0.9% | 150,401 | $332K |
| 8 | Ikarian Capital, LLC | 0.8% | 133,517 | $295K |
| 9 | BlackRock, Inc. | 0.7% | 114,122 | $252K |
| 10 | VANGUARD FIDUCIARY TRUST CO | 0.5% | 80,653 | $178K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.